Eagle pharmaceuticals, inc. (EGRX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13
ASSETS
Current assets:
Cash and cash equivalents

202,016

109,775

117,211

108,128

102,139

78,791

91,226

100,247

95,670

114,657

97,545

55,385

27,710

52,820

59,311

75,563

78,287

79,083

71,979

13,686

99,924

34,869

22,722

49,790

54,879

10,455

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,000

89,999

15,998

0

19,999

-

-

-

Accounts receivable, net

54,491

48,004

44,812

60,339

63,930

66,486

78,461

69,403

53,426

53,821

71,601

53,230

84,742

42,194

47,050

52,027

26,526

26,267

12,218

12,982

10,508

11,956

7,296

6,712

7,820

5,124

Inventory, Net

8,434

6,566

7,247

11,594

10,265

8,304

7,273

6,444

6,141

5,118

4,878

3,587

3,015

2,739

7,106

6,363

7,761

15,042

7,348

2,325

2,018

1,242

1,294

329

-

0

Prepaid Expense and Other Assets, Current

10,631

15,104

10,516

5,598

5,895

10,263

20,810

25,502

13,583

15,101

8,130

11,664

8,105

11,357

5,578

1,546

2,048

1,865

4,757

1,559

1,340

1,640

1,711

922

832

1,902

Total current assets

275,572

179,449

179,786

185,659

182,229

163,844

197,770

201,596

168,820

188,697

182,154

123,866

123,572

109,110

119,045

135,499

114,622

122,257

120,302

120,551

129,788

49,707

53,022

57,755

63,532

17,482

Property and equipment, net

2,423

2,202

2,319

2,258

2,333

2,397

2,553

2,773

6,498

6,820

4,365

3,768

3,796

3,316

2,827

2,813

2,869

2,205

1,803

374

100

342

344

359

377

402

Intangible assets, net

14,917

15,583

16,213

16,843

17,473

18,103

18,702

19,302

22,652

23,322

24,002

31,949

32,660

33,372

24,759

10,960

11,116

0

-

-

-

-

-

-

-

-

Goodwill

39,743

39,743

39,743

39,743

39,743

39,743

39,743

39,743

39,743

39,743

39,743

39,743

39,743

39,743

-

-

-

0

-

-

-

-

-

-

-

-

Deferred tax asset, net

13,759

13,669

13,997

13,949

14,109

13,822

9,314

9,817

11,477

11,354

16,502

20,275

24,431

28,643

-

-

-

0

-

-

-

-

-

-

-

-

Other assets

15,530

3,908

4,980

3,178

3,565

694

706

706

106

124

124

578

618

136

94

94

94

143

111

104

45

45

45

45

45

46

Deferred initial public offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

171

Total assets

361,944

254,554

257,038

261,630

259,452

238,603

268,788

273,937

249,296

270,060

266,890

220,179

224,820

214,320

146,725

149,366

128,701

124,605

122,216

121,029

129,933

50,094

53,411

58,159

63,955

18,102

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

9,756

5,462

11,232

17,296

16,786

9,917

7,544

18,266

9,353

11,981

8,902

12,148

19,027

14,716

13,104

11,431

10,295

3,857

14,148

4,783

5,435

3,501

4,059

2,520

2,458

1,192

Accrued Liabilities, Current

20,123

28,361

27,127

29,450

22,436

23,519

22,867

23,222

13,102

15,391

20,438

18,680

15,399

25,237

21,331

23,336

19,561

24,405

14,439

13,538

15,029

12,165

9,671

7,468

7,115

3,129

Current portion of contingent consideration

-

-

-

-

-

-

0

0

55

15,055

55

1,125

1,012

1,012

1,012

1,012

1,012

0

-

-

-

-

-

-

-

-

Current portion of long-term debt

116,000

5,000

4,000

5,000

5,000

6,250

5,000

6,250

6,250

4,875

5,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

6,000

6,000

6,260

6,585

6,520

6,585

6,259

9,694

10,019

Total current liabilities

145,879

38,823

42,359

51,746

44,222

39,686

35,411

47,738

28,760

47,302

34,395

31,953

35,438

40,965

35,447

35,779

30,868

34,262

34,587

24,581

27,049

22,186

20,315

16,248

19,268

14,341

Other long-term liabilities

3,454

3,000

3,227

1,560

2,870

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration, less current portion

-

-

-

-

-

-

0

0

735

709

17,482

22,864

22,555

22,129

5,755

5,753

5,517

0

-

-

-

-

-

-

-

-

Long-term debt, less current portion

30,781

33,557

35,687

35,843

36,999

38,155

39,312

40,468

41,624

42,905

43,936

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

180,114

75,380

-

-

-

77,841

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Redeemable Series C Preferred Stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,706

Commitments and Contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, 1,500,000 shares authorized and no shares issued or outstanding as of March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value; 50,000,000 shares authorized; 16,597,814 and 16,537,846 shares issued as of March 31, 2020 and December 31, 2019, respectively

17

17

17

17

17

17

16

16

16

16

16

16

16

16

15

15

15

15

15

15

15

14

14

14

14

3

Additional paid in capital

285,044

278,518

273,153

267,479

262,084

256,458

251,875

245,470

237,059

233,639

229,655

225,892

220,202

213,872

206,465

202,729

200,309

197,440

195,945

194,596

192,855

137,577

137,259

136,970

136,812

14,203

Retained earnings

69,629

72,500

71,495

73,885

67,160

58,187

45,597

31,559

28,900

26,284

17,199

1,768

-2,735

-25,659

-82,960

-94,910

-108,008

-107,112

-108,331

-98,163

-89,986

-109,683

-104,177

-95,073

-92,139

-102,136

Treasury stock, at cost, 2,933,320 and 2,907,687 shares as of March 31, 2020 and December 31, 2019, respectively

172,860

171,861

168,900

168,900

153,900

153,900

103,423

91,314

87,798

80,795

75,793

62,314

50,656

37,003

17,997

-

-

0

-

-

-

-

-

-

-

-

Stockholders' Equity Attributable to Parent

181,830

179,174

175,765

172,481

175,361

160,762

194,065

185,731

178,177

179,144

171,077

165,362

166,827

151,226

105,523

107,834

92,316

90,343

87,629

96,448

102,884

27,908

33,096

41,910

44,686

-87,929

Total liabilities and stockholders' equity

361,944

254,554

257,038

261,630

259,452

238,603

268,788

273,937

249,296

270,060

266,890

220,179

224,820

214,320

146,725

149,366

128,701

124,605

122,216

121,029

129,933

50,094

53,411

58,159

63,955

18,102